(HSAI) Hesai Sponsored - Overview
Sector: Consumer Cyclical | Industry: Auto Parts | Exchange: NASDAQ (USA) | Market Cap: 3.182m USD | Total Return: -3% in 12m
Avg Turnover: 26.8M
Qual. Beats: 0
Rev. Trend: 96.6%
Qual. Beats: 0
Warnings
Share dilution 24.1% YoY
Beneish M-Score -0.74 > -1.5 - likely earnings manipulation
Choppy Below Avwap Earnings
Tailwinds
Confidence
Hesai Group (HSAI) is a Shanghai-based developer and manufacturer of three-dimensional light detection and ranging (LiDAR) technology. The company serves global markets, including North America and Europe, providing sensor solutions for passenger vehicles equipped with Advanced Driver Assistance Systems (ADAS) and autonomous mobility fleets. Beyond automotive use, its hardware is integrated into industrial robotics for logistics, last-mile delivery, and environmental monitoring through gas detection products.
The LiDAR sector is characterized by high R&D intensity and a shift toward solid-state designs to improve durability and reduce unit costs for mass-market vehicle integration. As a Tier 1 supplier, Hesais business model relies on securing long-term design wins with original equipment manufacturers (OEMs) to drive high-volume production cycles. Investors can find more detailed financial metrics and valuation models on ValueRay. The company operates within the broader autonomous driving ecosystem, where hardware reliability and software integration are primary competitive moats.
- Mass production scaling for ADAS-equipped passenger vehicles drives top-line revenue growth
- US-China trade tensions and potential LiDAR import restrictions create regulatory volatility
- Manufacturing cost reductions through proprietary ASIC development improve gross profit margins
- Demand volatility in the global robotaxi and autonomous delivery robot sectors
- Market share competition among Chinese LiDAR manufacturers pressures average selling prices
| Net Income: 468.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA 1.84 > 1.0 |
| NWC/Revenue: 200.4% < 20% (prev 153.1%; Δ 47.32% < -1%) |
| CFO/TA 0.01 > 3% & CFO 113.8m > Net Income 468.2m |
| Net Debt (-4.66b) to EBITDA (174.0m): -26.79 < 3 |
| Current Ratio: 4.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (163.2m) vs 12m ago 24.11% < -2% |
| Gross Margin: 41.22% > 18% (prev 0.43%; Δ 4.08k% > 0.5%) |
| Asset Turnover: 37.88% > 50% (prev 38.50%; Δ -0.62% > 0%) |
| Interest Coverage Ratio: 2.98 > 6 (EBITDA TTM 174.0m / Interest Expense TTM 16.9m) |
| A: 0.58 (Total Current Assets 7.93b - Total Current Liabilities 1.59b) / Total Assets 10.9b |
| B: -0.27 (Retained Earnings -2.94b / Total Assets 10.9b) |
| C: 0.01 (EBIT TTM 50.3m / Avg Total Assets 8.34b) |
| D: -1.53 (Book Value of Equity -3.02b / Total Liabilities 1.97b) |
| Altman-Z'' = 1.37 = BB |
| DSRI: 0.83 (Receivables 1.16b/993.2m, Revenue 3.16b/2.24b) |
| GMI: 1.04 (GM 41.22% / 43.00%) |
| AQI: 4.48 (AQ_t 0.16 / AQ_t-1 0.04) |
| SGI: 1.41 (Revenue 3.16b / 2.24b) |
| TATA: 0.03 (NI 468.2m - CFO 113.8m) / TA 10.9b) |
| Beneish M = -0.74 (Cap -4..+1) = D |
As of May 25, 2026, the stock is trading at USD 20.63 with a total of 2,552,699 shares traded.
Over the past week, the price has changed by -8.07%,
over one month by -7.65%,
over three months by -23.51% and
over the past year by -2.96%.
Hesai Sponsored has received a consensus analysts rating of 4.64. Therefore, it is recommended to buy HSAI.
- StrongBuy: 10
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 30.1 | 46% |
Market Cap CNY = 21.6b (3.18b USD * 6.7948 USD.CNY)
P/E Trailing = 43.0851
P/E Forward = 31.25
P/S = 0.9998
P/B = 2.4245
P/EG = 0.7105
Revenue TTM = 3.16b CNY
EBIT TTM = 50.3m CNY
EBITDA TTM = 174.0m CNY
Long Term Debt = 258.2m CNY (from longTermDebt, last quarter)
Short Term Debt = 625.8m CNY (from shortTermDebt, last quarter)
Debt = 1.04b CNY (from shortLongTermDebtTotal, last quarter) + Leases 76.8m
Net Debt = -4.66b CNY (calculated: Debt 1.04b - CCE 5.70b)
Enterprise Value = 17.0b CNY (21.6b + Debt 1.04b - CCE 5.70b)
Interest Coverage Ratio = 2.98 (Ebit TTM 50.3m / Interest Expense TTM 16.9m)
EV/FCF = -90.62x (Enterprise Value 17.0b / FCF TTM -187.1m)
FCF Yield = -1.10% (FCF TTM -187.1m / Enterprise Value 17.0b)
FCF Margin = -5.92% (FCF TTM -187.1m / Revenue TTM 3.16b)
Net Margin = 14.81% (Net Income TTM 468.2m / Revenue TTM 3.16b)
Gross Margin = 41.22% ((Revenue TTM 3.16b - Cost of Revenue TTM 1.86b) / Revenue TTM)
Gross Margin QoQ = 39.09% (prev 41.03%)
Tobins Q-Ratio = 1.56 (Enterprise Value 17.0b / Total Assets 10.9b)
Interest Expense / Debt = 1.63% (Interest Expense 16.9m / Debt 1.04b)
Taxrate = 0.01% (1.99k / 18.2m)
NOPAT = 50.3m (EBIT 50.3m * (1 - 0.01%))
Current Ratio = 4.97 (Total Current Assets 7.93b / Total Current Liabilities 1.59b)
Debt / Equity = 0.12 (Debt 1.04b / totalStockholderEquity, last quarter 8.89b)
Debt / EBITDA = -26.79 (Net Debt -4.66b / EBITDA 174.0m)
Debt / FCF = 24.92 (negative FCF - burning cash) (Net Debt -4.66b / FCF TTM -187.1m)
Total Stockholder Equity = 7.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.61% (Net Income 468.2m / Total Assets 10.9b)
RoE = 4.37% (Net Income TTM 468.2m / Total Stockholder Equity 10.7b)
RoCE = 0.46% (EBIT 50.3m / Capital Employed (Equity 10.7b + L.T.Debt 258.2m))
RoIC = 0.51% (NOPAT 50.3m / Invested Capital 9.89b)
WACC = 13.00% (E(21.6b)/V(22.7b) * Re(13.55%) + D(1.04b)/V(22.7b) * Rd(1.63%) * (1-Tc(0.00)))
Discount Rate = 13.55% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 91.11 | Cagr: 11.98%
[DCF] Fair Price = unknown (Cash Flow -187.1m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.24 | # QB: 0
Revenue Correlation: 96.60 | Revenue CAGR: 27.50% | SUE: 0.04 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.55 | Chg30d=+12.16% | Revisions=N/A | Analysts=1
EPS next Quarter (2026-09-30): EPS=1.28 | Chg30d=-26.71% | Revisions=N/A | Analysts=1
EPS current Year (2026-12-31): EPS=3.97 | Chg30d=-3.79% | Revisions=-45% | GrowthEPS=+5.5% | GrowthRev=+43.4%
EPS next Year (2027-12-31): EPS=6.31 | Chg30d=-0.32% | Revisions=-45% | GrowthEPS=+59.1% | GrowthRev=+41.3%
[Analyst] Revisions Ratio: -45%